2010
DOI: 10.1371/journal.pone.0010591
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Diabetes in NOD Mice by Repeated Exposures to a Contact Allergen Inducing a Sub-Clinical Dermatitis

Abstract: BackgroundType 1 diabetes is an autoimmune disease, while allergic contact dermatitis although immune mediated, is considered an exposure driven disease that develops due to epicutanous contact with reactive low-molecular chemicals. The objective of the present study was to experimentally study the effect of contact allergens on the development of diabetes in NOD mice. As the link between contact allergy and diabetes is yet unexplained we also examined the effect of provocation with allergens on Natural Killer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 32 publications
1
5
0
Order By: Relevance
“…The opposing theory is that CA modulates the immune system and lowers the risk of RA. Mortz et al (9) showed that CA is already prevalent in children and adolescents, and, furthermore, we have shown that CA can prevent the development of diabetes in the non-obese diabetic mouse, which is prone to develop diabetes type 1 (10).…”
Section: Discussionsupporting
confidence: 65%
“…The opposing theory is that CA modulates the immune system and lowers the risk of RA. Mortz et al (9) showed that CA is already prevalent in children and adolescents, and, furthermore, we have shown that CA can prevent the development of diabetes in the non-obese diabetic mouse, which is prone to develop diabetes type 1 (10).…”
Section: Discussionsupporting
confidence: 65%
“…Treatment with probiotics has been suggested, but no final human results exist so far (104). Allergen induction of a minor eczema, which seems to facilitate proliferation of NKT cells, reduces diabetes incidence in NOD mice, which is likely to reflect the decreased risk of T1D in humans with allergic dermatitis (105). Treatment with α-GalCer might be considered, but caution regarding the effect on other organ systems may be the reason for the lack of human trials.…”
Section: The Innate Immune Systemmentioning
confidence: 99%
“…Blood glucose monitoring for low-dose STZ experiments were performed daily between day 7-14 and thereafter once a week. Animals were considered diabetic when two consecutive measurements exceeded 14 mmol/l (Engkilde et al, 2010) Animals were killed and samples collected 48 hours after high-dose STZ treatment and 15 or 35 days after low-dose STZ.…”
Section: Stz Treatmentsmentioning
confidence: 99%